Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

25 trials with published results (8%)

Research Maturity

109 completed trials (36% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.4%

16 terminated out of 299 trials

Success Rate

87.2%

+0.7% vs benchmark

Late-Stage Pipeline

9%

26 trials in Phase 3/4

Results Transparency

23%

25 of 109 completed with results

Key Signals

25 with results87% success16 terminated

Data Visualizations

Phase Distribution

177Total
Not Applicable (90)
Early P 1 (4)
P 1 (11)
P 2 (46)
P 3 (11)
P 4 (15)

Trial Status

Completed109
Recruiting69
Unknown69
Terminated16
Not Yet Recruiting15
Active Not Recruiting8

Trial Success Rate

87.2%

Benchmark: 86.5%

Based on 109 completed trials

Clinical Trials (299)

Showing 20 of 20 trials
NCT03295279Enrolling By Invitation

WTC Chest CT Imaging Archive

NCT04624490Phase 1Recruiting

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

NCT04708782Phase 3Completed

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

NCT07179380Phase 3Recruiting

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT04905693Phase 3Enrolling By Invitation

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

NCT05776225Active Not RecruitingPrimary

Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

NCT05830318Completed

Usability and Acceptability Study of the P-STEP Mobile Application

NCT03297775Recruiting

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

NCT07561034Not ApplicableNot Yet Recruiting

The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease

NCT00678821Phase 2Completed

Aerobic Exercise in Patients With Pulmonary Hypertension

NCT05631756Not ApplicableCompletedPrimary

Correlation Between PaO2/FiO2 and Lung Ultrasound Score in the Intensive Care Unit

NCT06235645Recruiting

dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasound

NCT04619680Phase 4Completed

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

NCT06388421Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT03478826RecruitingPrimary

Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

NCT05943535Phase 3Recruiting

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

NCT05649722Phase 2Completed

An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT05746039Phase 1Recruiting

Feasibility of Semaglutide in Advanced Lung Disease

NCT07541638Not ApplicableRecruiting

Early Recognition of Progressive Lung Fibrosis in Systemic Rheumatic Diseases

NCT05417776Phase 2RecruitingPrimary

Collagen-targeted PET Imaging for Early Interstitial Lung Disease

Scroll to load more

Research Network

Activity Timeline